These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1875158)

  • 1. Social impact of stimulant treatment for hyperactive children.
    Whalen CK; Henker B
    J Learn Disabil; 1991 Apr; 24(4):231-41. PubMed ID: 1875158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulant medication and parent training therapies for attention deficit-hyperactivity disorder.
    Anastopoulos AD; DuPaul GJ; Barkley RA
    J Learn Disabil; 1991 Apr; 24(4):210-8. PubMed ID: 1875156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
    Stevenson RD; Wolraich ML
    Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of stimulant medication on learning in children with ADHD.
    Swanson JM; Cantwell D; Lerner M; McBurnett K; Hanna G
    J Learn Disabil; 1991 Apr; 24(4):219-30, 255. PubMed ID: 1875157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of stimulant medication with children.
    Phillips S
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate and interpersonal relationships of children with attention deficit hyperactivity disorder.
    Mino Y; Ohara H
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):45-51. PubMed ID: 1753489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperactive children treated with stimulants. Is cognitive training a useful adjunct?
    Abikoff H; Gittelman R
    Arch Gen Psychiatry; 1985 Oct; 42(10):953-61. PubMed ID: 2864027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stimulant therapy in children].
    Steinhausen HC
    Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug treatment for hyperactive children. Therapeutic guidelines.
    Elia J
    Drugs; 1993 Nov; 46(5):863-71. PubMed ID: 7507036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does stimulant medication improve the peer status of hyperactive children?
    Whalen CK; Henker B; Buhrmester D; Hinshaw SP; Huber A; Laski K
    J Consult Clin Psychol; 1989 Aug; 57(4):545-9. PubMed ID: 2768616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 17. Social judgment processes in hyperactive boys: effects of methylphenidate and comparisons with normal peers.
    Whalen CK; Henker B; Granger DA
    J Abnorm Child Psychol; 1990 Jun; 18(3):297-316. PubMed ID: 2198308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder.
    Zametkin AJ; Linnoila M; Karoum F; Sallee R
    Am J Psychiatry; 1986 Mar; 143(3):359-62. PubMed ID: 2420216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder.
    Castellanos FX; Elia J; Kruesi MJ; Marsh WL; Gulotta CS; Potter WZ; Ritchie GF; Hamburger SD; Rapoport JL
    Neuropsychopharmacology; 1996 Feb; 14(2):125-37. PubMed ID: 8822535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of methylphenidate effects on hyperactive children's peer interactions.
    Granger DA; Whalen CK; Henker B
    J Abnorm Child Psychol; 1993 Oct; 21(5):535-49. PubMed ID: 8294652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.